Anuj Sharma is the Co-Founder and CEO of Decrypt Biomedicine, a biotech developing first-in-class small-molecule treatments for autoimmune disease by drugging 'cryptic' binding sites on hard-to-target proteins. He co-founded the company with Greg Bowman and holds a B.A. and an M.S. from Columbia University.